Veozah vs Gabapentin for Hot Flashes: Which Should You Ask About?
Independent editorial research — not medical advice, and not medically reviewed by a clinician.
Here’s the short version before you scroll another inch.
Veozah (fezolinetant)
Brand-name pill the FDA approved specifically for moderate-to-severe hot flashes and night sweats. Not a hormone. Works well — but costs roughly $690–$772/monthat full retail and carries the FDA’s strongest safety warning for rare liver injury, so you’ll need blood tests.
Gabapentin (off-label)
A cheap generic used off-labelfor hot flashes — not FDA-approved for this use, but Menopause-Society-recommended with Level I evidence. Costs about $9–$11/month with a coupon. Drowsiness can be an asset at bedtime. State rules vary.
Both are real options that real women use. You’re not being reckless for wanting relief. Let’s make the choice clear.
Best for / not for you
Ask about Veozah first if you…
- ✓Have moderate-to-severe hot flashes or night sweats as your main problem
- ✓Want a medicine the FDA approved specifically for hot flashes
- ✓Can’t take or don’t want hormones
- ✓Have commercial insurance, or can handle the cost
- ✓Are okay with blood tests to check your liver
Ask about gabapentin first if you…
- ✓Are mainly losing sleep to night sweats
- ✓Want the lowest-cost option
- ✓Can tolerate some drowsiness (often dosed at bedtime, where it can actually help)
- ✓Understand it’s used off-label for menopause — and that a handful of states treat it as a controlled substance
Neither one is enough on its own if you…
- →Also have vaginal dryness, painful sex, or urinary symptoms
- →Have a bigger mix of menopause symptoms (mood, brain fog, low libido, bone worries)
- →Have complex liver, kidney, lung, or cancer-treatment history that needs an in-person look first
Veozah vs gabapentin at a glance
| If your top priority is… | Ask about first | Why |
|---|---|---|
| FDA-approved for hot flashes | Veozah | Approved for moderate-to-severe hot flashes/night sweats from menopause |
| Lowest cost | Gabapentin | Generic; often about $9–$11 a month with a coupon |
| Sleep wrecked by night sweats | Gabapentin | A bedtime dose can calm night sweats and help you sleep |
| Staying sharp (no daytime fog) | Veozah | Not a sedative; gabapentin commonly causes drowsiness |
| Skipping blood-test monitoring | Gabapentin | Veozah requires liver blood tests before and during use |
| A full menopause plan | Neither alone | Use the tool below to match your whole situation |
The HRT Indexis the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated.
This isn’t a one-size answer. The right non-hormonal option depends on your symptoms, your risk history, your insurance, and your state. Some situations belong with an in-person clinician first.
Check your safest next step with Find My HRT PathThe full comparison: Veozah vs gabapentin, side by side
Most pages describe each drug on its own and leave you to do the math. We built the table we wish existed — every row is a real decision, and every fact is sourced and dated below.
Last verified: July 2026. Sources listed at the end of the page.
| Decision factor | Veozah (fezolinetant) | Gabapentin (used off-label) |
|---|---|---|
| FDA-approved for hot flashes? | Yes — approved May 2023 for moderate-to-severe hot flashes/night sweats from menopause. First of its kind (an “NK3 receptor blocker”). | No — used off-label. FDA-approved for seizures and shingles nerve pain, not hot flashes. |
| Is it a hormone? | No. Non-hormonal. | No. A nerve medicine (an “anticonvulsant”). |
| How well it works | In two large trials, about 2.5 fewer hot flashes per day than placebo at 12 weeks — roughly a 60% drop from where women started. Relief begins within a week. | In trials, about 35–50% fewer at 900 mg/day; one well-known study showed a 45% drop in frequency. Off-label for menopause. |
| The Menopause Society’s rating | Recommended — Level I (strongest) evidence. Note: this rating came out before the liver warning below. | Recommended — Level I (strongest) evidence. |
| Typical dose | 45 mg — one pill, once a day. Simple. | 900–2,400 mg/day, built up slowly; often started at bedtime. |
| Biggest strength | Targeted, once-daily, no drowsiness. | Very cheap; the drowsiness can help if night sweats ruin your sleep. |
| Common side effects | Stomach pain, diarrhea, trouble sleeping, back pain, higher liver enzymes. | Dizziness, drowsiness, unsteadiness, swelling in the limbs. |
| Serious safety flag | ⚠️ FDA “boxed warning” (Dec 2024) for rare but serious liver injury. | FDA warning (2019) about serious breathing problems when combined with opioids/sedatives or in people with COPD or older age. |
| Monitoring | Liver blood test before starting, then monthly for 3 months, at 6 months, and 9 months. | No routine blood monitoring; dose is lowered if kidneys are weak. |
| Controlled substance? | No. | Not federally — but a handful of states treat it as a Schedule V controlled substance. Check yours. |
| Cost without insurance | ~$690–$772/month full retail; ~$474–$485 with a discount card. No generic yet. | ~$9–$11/month with a coupon (about $149 full retail for a 90-count of 300 mg). |
| Insurance help | Savings card: $0 first month, then ~$30/refill — commercial insurance only (up to $4,000/year; not Medicare/Medicaid). | Covered by most plans as a cheap generic; coupons usually beat copays. |
| What it does NOT treat | Vaginal dryness, painful sex, urinary symptoms, bone loss. | Same — hot flashes/night sweats only. |
| Best next step | Ask a clinician if it fits your liver, kidneys, meds, and coverage. | Ask a clinician if it fits your sleep, kidneys, other meds, and daytime needs. |
Sources: FDA approval and prescribing information; The Lancet (SKYLIGHT 1) and JCEM (SKYLIGHT 2); The Menopause Society 2023 Nonhormone Therapy Position Statement; FDA Drug Safety Communications (Veozah liver, Dec 2024; gabapentinoid breathing risk, Dec 2019); GoodRx and SingleCare pricing (July 2026); Astellas VEOZAH Savings Program terms.
The honest bottom line:Veozah is a single, no-fog daily pill that’s approved for exactly this — but it’s pricey, brand-only, and comes with a real liver warning and blood tests. Gabapentin is pocket change, shines when night sweats wreck your sleep, and is Menopause-Society-recommended — but it’s off-label, usually causes drowsiness, and takes some dose-tinkering. Neither one touches vaginal or urinary symptoms.
Which works better for hot flashes — Veozah or gabapentin?
What the Veozah trials showed
Veozah’s approval rests on the SKYLIGHT trials— two large studies where women started with at least 7 moderate-to-severe hot flashes a day. On the 45 mg dose:
- ›By week 12, hot flashes dropped by about 2.5 more per day than placebo (2.55 fewer per day in SKYLIGHT 1; 2.53 in SKYLIGHT 2). That gap is statistically solid.
- ›From where women started, that’s roughly a 60% drop in how often hot flashes hit.
- ›Relief showed up as early as week 1 and held for a year.
Why does the “2.5 more than placebo” number matter? In hot-flash studies, placebo alone helps a lot — the fair test is how much more the drug does than a sugar pill. Veozah clears that bar.
What gabapentin’s studies showed
Gabapentin isn’t FDA-approved for hot flashes, but it has real evidence behind it. In randomized trials, 900 mg a day cut hot flashes by roughly 35–50%. One well-known study found a 45% drop in how often they hit and about a 54% drop in a combined score of frequency and severity. Higher doses can do a little more, but the trade is more drowsiness and dizziness.
The honest read on “better”
Veozah’s trials and gabapentin’s trials are separate studies, with different designs, doses, and patients. No one has run a head-to-head trial putting the two against each other.So we won’t tell you Veozah “beats” gabapentin, because the evidence doesn’t say that.
What the evidence doessay: Veozah is the cleaner match for a hot-flash label because it’s approved for exactly this. Gabapentin is off-label but genuinely effective, and it brings a bonus at night. Which one is right for you comes down to cost, sleep, and safety — not a made-up scoreboard.
For scale: if maximum relief is all you care about and you’re a candidate, hormone therapy is still the most effective treatment for hot flashes — a conversation worth having.
Is Veozah’s liver warning a dealbreaker?
⚠ FDA Boxed Warning — Veozah (December 2024)
A “boxed warning” is the most serious warning the FDA puts on a drug. Veozah got one in December 2024 after a report of a patient who developed serious liver injury about 40 daysinto treatment. After stopping the drug, the person’s liver recovered. That’s the pattern the monitoring is designed to catch early. (Veozah’s FDA label was updated February 2026 to reflect all of this.)
The monitoring schedule, plain and simple
| When | What happens |
|---|---|
| Before you start | Liver blood test. You shouldn’t start Veozah if your ALT or AST (two liver enzymes) is at least 2× the upper limit of normal (ULN) — or if your total bilirubin is at least 2× ULN. |
| Month 1 | Liver blood test |
| Month 2 | Liver blood test |
| Month 3 | Liver blood test |
| Month 6 | Liver blood test |
| Month 9 | Liver blood test |
| Any time | Stop Veozah and call your doctor if you get yellow skin or eyes, dark urine, pale stools, nausea, unusual tiredness, itching, or belly pain. |
Who shouldn’t take Veozah
Veozah is off the table if you have known cirrhosis, severe kidney disease or end-stage renal disease, or you take a “CYP1A2 inhibitor” — a type of drug (including some antidepressants and the antibiotic ciprofloxacin) that blocks how your body clears Veozah. Your clinician checks this against your medication list.
Honest context:in the trials, serious liver issues were rare, mostly showed no symptoms, and reversed when the drug stopped. The warning is serious enough to respect and monitor — notserious enough that it automatically rules Veozah out for a woman with healthy liver labs who wants it. That’s a call to make with a clinician who runs the tests.
Gabapentin’s safety picture
Gabapentin’s main concern is the opposite kind: it can make you drowsy, dizzy, or unsteady, especially at first. There’s also an FDA warning from 2019 that gabapentin can cause serious breathing problems when combined with opioids or other sedatives, or in people with COPD or older age. For an otherwise-healthy woman not on those medicines, that risk is much lower — but it’s why your full medication list matters.
The HRT Index may earn a commission if you use some provider links below. It doesn’t change our verification or our recommendations.
Which costs more — Veozah or gabapentin?
| Price check (July 2026) | Veozah (30 tablets, 45 mg) | Gabapentin (90 capsules, 300 mg ≈ 900 mg/day) |
|---|---|---|
| Average retail, no coupon | ~$690–$772/month | ~$149/month |
| With a free discount card (GoodRx/SingleCare) | ~$474–$485/month | ~$9–$11/month |
| Manufacturer savings card | $0 first month, then ~$30/refill — commercial insurance only; up to $4,000/year; not valid with Medicare or Medicaid | Not needed (already a cheap generic) |
| Generic available? | No — patents run into 2034, so a cheaper version isn’t coming soon | Yes |
- ›Veozah’s price swings by pharmacy — sometimes $100+ between two stores in the same town, so it pays to compare on GoodRx or SingleCare before you fill.
- ›The savings card is the game-changer, but only with commercial insurance. If you have Medicare or Medicaid, you can’t use it — and Veozah can get expensive fast. Astellas also runs a patient-assistance program for uninsured, qualifying patients.
- ›Gabapentin is cheap even without insurance. For a typical hot-flash dose (about 900 mg a day), a free coupon usually lands it under about $11 a month. If your insurance copay is higher than the coupon, just use the coupon.
Which is better for night sweats and sleep?
Night sweats are a different job than daytime flashes. You’re not asking “which drug has the best label?” You’re asking, “which one lets me sleep without feeling useless in the morning?”
That’s where gabapentin’s biggest downside becomes an upside. Taken at bedtime, the same drowsiness that’s annoying during the day can help you fall — and stay — asleep while it dials down the sweats. The Menopause Society specifically notes gabapentin is most useful when symptoms are worst at night.
Gabapentin at bedtime
May help you sleep — and can calm night sweats at the same time. The trade-off: possible next-day grogginess or dizziness, especially the first couple of weeks.
Veozah (once-daily)
Targets hot flashes day and night but isn’t a sleep aid, and can actually cause insomnia for some women. No daytime fog from sedation.
Quick way to sort it: if night sweats and broken sleep are your whole problem, gabapentin is worth asking about first. If you’re flashing all day and can’t afford grogginess, lean Veozah. And if insomnia is already severe on its own, tell your clinician before you start either — it changes the plan.
The one catch nobody tells you: neither drug is a full menopause plan
That’s not a flaw if hot flashes or night sweats are your whole problem— they’re excellent at that one job. But if you’re also dealing with vaginal dryness, painful sex, urinary changes, mood swings, brain fog, low libido, or bone worries, then picking “Veozah or gabapentin” is answering the wrong question. You’d fix the flashes and still feel awful.
| If you also have… | The better conversation is… |
|---|---|
| Vaginal dryness or painful sex | Local (vaginal) estrogen or other vaginal treatments — not a hot-flash pill |
| Urinary symptoms | A genitourinary (GSM) evaluation |
| Mood, brain fog, or a mix of symptoms | A broader menopause care plan |
| Bone-loss worries | A bone-health assessment |
| Hot flashes only | A hot-flash medicine like the two on this page |
Who is Veozah usually the better fit for?
You’re probably a good fit to ask about Veozah if:
- ✓Hot flashes or night sweats are your main symptom (not a broad mix).
- ✓You want an FDA-approved non-hormonal option — approval means it was tested and cleared for exactly this use.
- ✓You can’t take or don’t want hormones — for example, a history of certain cancers, blood clots, or personal preference.
- ✓You need to stay sharp during the day and don’t want a sedating medicine.
- ✓You have commercial insurance (the savings card makes the price realistic) or can cover the cost.
- ✓Your liver is healthy and you can keep up with the blood tests.
You’re probably notthe right fit — and gabapentin or another route may serve you better — if cost is a hard limit, you have liver disease, severe kidney disease, or you take a drug that clashes with Veozah.
Who is gabapentin usually the better fit for?
You’re probably a good fit to ask about gabapentin if:
- ✓Your worst symptoms hit at night and wreck your sleep.
- ✓Cost matters more than having a newer brand-name drug.
- ✓You can handle some drowsiness — often an upside at bedtime.
- ✓You already have a nerve-pain reason your clinician knows about.
- ✓You understand it’s off-label for hot flashes, and you’re comfortable asking why it’s the pick.
State heads-up:gabapentin isn’t a federally controlled substance, but Alabama, Kentucky, North Dakota, Tennessee, Utah, Virginia, and West Virginia classify it as a Schedule V controlled substance (Michigan did too, then reversed in 2024). In those states, refills and prescribing are tighter, and getting it through telehealth can be harder. State lists change, so check yours.
Be extra careful — and make sure your clinician knows — if you take opioids, sedatives, or sleep meds, drink alcohol regularly, have COPD or another lung condition, have kidney problems, are older, or need to drive or work without grogginess.The FDA’s breathing-risk warning applies most to those situations.
Can gabapentin cause swelling, weight gain, or mood changes?
Here are the specifics from gabapentin’s own labeling (measured in its nerve-pain trials):
- ›Dizziness: about 21–28% of people, versus 5–8% on placebo.
- ›Drowsiness: about 16–21%, versus 5% on placebo.
- ›Swelling in the limbs (peripheral edema): about 8%, versus 2% on placebo. Some people also see modest weight gain.
Most of the dizziness and drowsiness tends to ease within the first few weeks as your body adjusts, though that varies by person and dose. The swelling is usually mild but worth flagging if it shows up.
On mood: gabapentin belongs to the anticonvulsant family, and that whole class carries an FDA warning about a small increase in suicidal thoughts or behavior. It’s not specific to menopause, and it’s not common — but if you or someone close to you notices new depression, anxiety, or dark thoughts after starting it, that’s a call-your-doctor-now situation, not a wait-and-see one.
Can you take Veozah and gabapentin together?
This is a question for a clinician, not a do-it-yourself combo. Even if a drug checker shows no obvious clash, the real issues are your full medication list, your liver and kidney health, your total sedation load, and whether adding a second drug actually helps or just piles on side effects.
If one option alone isn’t controlling your symptoms, that’s the exact conversation to bring to a menopause clinician: Why combine them? What is each one for? What side effects overlap? What do I stop first if I feel worse?
How do Veozah and gabapentin compare to HRT, Lynkuet, Brisdelle, and other options?
Veozah and gabapentin are two non-hormonal choices, but they aren’t the whole menu. Other options include hormone therapy for eligible women, a newer non-hormonal drug called Lynkuet, low-dose paroxetine (Brisdelle), other antidepressants used off-label, and oxybutynin. If neither of our two headliners feels right, you still have paths.
| Option | What it is | Best-known role | Key caution |
|---|---|---|---|
| Hormone therapy (HRT) | Estrogen (± progestogen) | The most effective option for hot flashes in many eligible women | Fit depends on age, timing, whether you have a uterus, and health history |
| Veozah (fezolinetant) | NK3 receptor blocker (non-hormonal) | FDA-approved non-hormonal hot-flash drug | Liver monitoring; drug interactions; brand-name cost |
| Lynkuet (elinzanetant) | NK1/NK3 receptor blocker (non-hormonal) | Newer FDA-approved non-hormonal hot-flash drug (2025) | Its own safety profile (see below); not the same drug as Veozah |
| Gabapentin | Nerve medicine (anticonvulsant) | Off-label; good for night-sweat-driven sleep loss | Drowsiness, dizziness, swelling; breathing-risk cautions; controlled in some states |
| Brisdelle (paroxetine 7.5 mg) | Low-dose SSRI | An FDA-approved non-hormonal hot-flash pill | Drug interactions (can matter with tamoxifen) |
| Other SSRIs/SNRIs | Antidepressants (off-label) | Hot flashes plus mood or anxiety | Sexual side effects, sleep changes, interactions |
| Oxybutynin | Bladder medicine (off-label) | Hot flashes plus urinary urgency | Dry mouth, constipation, memory caution in older adults |
A closer look at Lynkuet, since it’s the newest option and the most direct cousin to Veozah: it’s an FDA-approved (2025) NK1/NK3 receptor blocker for moderate-to-severe hot flashes, taken as 120 mg once daily at bedtime. Because it’s dosed at night and can cause drowsiness, some women find it helps sleep — but that same effect comes with a warning about next-day grogginess and driving. Like Veozah, it needs liver blood-test monitoring. It’s not for anyone who is or could become pregnant, shouldn’t be taken with grapefruit or certain interacting medicines, and carries a caution for people with a seizure history.
Two quick definitions: an “NK3 (or NK1) receptor blocker” just means the drug quiets a specific brain signal that drives hot flashes when estrogen drops. “Off-label”means a drug that’s FDA-approved for one thing but prescribed for another — legal, common, and often evidence-backed.
The takeaway: “Veozah vs gabapentin” isn’t the whole decision. If you’re a candidate for hormones and open to them, HRT is the most effective route. If you want non-hormonal, there are now several options. See our full non-hormonal options comparison.
What to ask your clinician before you choose
If you’re considering Veozah, ask:
- ?Am I a candidate based on my liver, kidneys, and other medicines?
- ?Which liver blood tests do I need before I start?
- ?Where and how will I get monthly labs for the first 3 months?
- ?What happens at the 6- and 9-month checks?
- ?What symptoms should make me stop and call you?
- ?What will my first fill and my next refill actually cost?
- ?Does my insurance need prior authorization?
If you’re considering gabapentin, ask:
- ?Why gabapentin instead of an FDA-approved hot-flash medicine?
- ?What dose and timing are you thinking, and how slowly do we build up?
- ?Will it affect my driving, work, or morning grogginess?
- ?Do any of my medicines raise my sedation or breathing risk?
- ?Do I need a lower dose because of my kidneys?
- ?Is gabapentin a controlled substance in my state, and does that change refills?
- ?How long do I try it before we call it? And how do I stop it safely?
And zoom out with these:
- ›Are hot flashes really my only target — or do I need to treat more?
- ›Should I also look at vaginal estrogen, an HRT discussion, a sleep check, or mood support?
- ›Is online care my right first step, or do I need to be seen in person?
Where to get evaluated for non-hormonal options
The HRT Index may earn a commission if you use some provider links. It doesn’t change our verification or our recommendations.
| Provider (verified July 2026) | Lists Veozah? | Lists gabapentin? | Labs | Insurance | Controlled-substance limit |
|---|---|---|---|---|---|
| Midi Health | Yes (publicly) | Yes (publicly) | Clinicians can order bloodwork | In-network with most PPO plans; not Medicare or Medicaid (Medicare members can pay out of pocket) | None stated for these drugs |
| Sesame | Not confirmed on its menopause list | Yes (publicly) | May order labs at the visit | Cash-pay only; doesn’t bill insurance | Cannot prescribe controlled substances online — so gabapentin isn’t available through Sesame in states that schedule it |
Find My HRT Path (our free tool)
If you’re not sure whether this is a hot-flashes-only issue or something broader, start with the tool. It matches your symptoms, risk history, insurance, and state to the right kind of visit — and flags when you should be seen in person first.
Use Find My HRT Path →Midi Health — menopause-focused visit
Midi’s clinicians publicly list both Veozah and gabapentinamong their prescriptions, they’re available in all 50 states, they’re in-network with most PPO plans, and they can order bloodwork— which matters because Veozah requires those liver labs. Midi also covers hot flashes, sleep trouble, vaginal dryness, brain fog, and mood, so if your picture is broader, they can still help.
Honest limits: not covered by Medicare or Medicaid. Medicare members can see Midi as self-pay; Midi can’t treat Medicaid members at all.
Check availability and insurance fit with Midi Health →Sesame — cash-pay option
Low-cost telehealth visits (from about $34) where a clinician can evaluate you for menopause treatment. Two honest caveats: Sesame doesn’t bill insurance (cash-pay, though the price is low), and its providers can’t prescribe controlled substances online— which means gabapentin isn’t an option through Sesame in the handful of states that schedule it.
Compare menopause visit options on Sesame →One safety flag
Online care may not be the right first step if you have complex liver disease, severe kidney disease, serious lung or breathing conditions, a complicated cancer-treatment history, unexplained bleeding, sudden severe symptoms, or medication interactions that need an in-person review. When in doubt, get seen.
Some readers discover partway through that they’re a candidate for hormone therapy and would prefer it — HRT is the most effective option for hot flashes. If that’s you, don’t force a non-hormonal fit. explore your HRT provider options via Find My HRT Path instead.
What real women say
We don’t use reviews to prove a drug works or is safe — that’s what the trials and the FDA are for. These are individual experiences, shared publicly, to show what the day-to-day can feel like. Your results may differ.
“I was prescribed gabapentin by my oncologist as my hot flashes and night sweats after breast cancer were getting out of control. They totally vanished from the first night of taking 300 mg before bedtime. I’m sleeping like a baby for the first time in months.”
— Patient review, Drugs.com (gabapentin for hot flashes). Individual experience; gabapentin is off-label for menopause; results vary.
“In the past I took Effexor, but I find Veozah to be much more effective… I did have to jump through a few hoops to get it covered by insurance, but ultimately it was covered.”
— “smiling_brenda,” Breastcancer.org (Veozah). Individual experience; coverage varies.
Notice what those two quotes capture together: gabapentin’s night-sweat-and-sleep sweet spot, and Veozah’s effectiveness alongside its very real insurance hassle. That’s the whole trade-off in two sentences.
What we actually verified
Under The HRT Index Verification Standard— reading every published price, separating FDA-approved from off-label and compounded options, checking availability, and re-verifying on a fixed schedule — here’s what we confirmed for this page, and when.
Verified July 2026:
- → Veozah: FDA approval and indication, 45 mg once-daily dosing, the December 2024 boxed warning for liver injury (label updated February 2026), the liver-monitoring schedule, contraindications, and common side effects
- → Veozah effectiveness: about 2.5 fewer hot flashes per day than placebo at week 12 — from The Lancet (SKYLIGHT 1) and JCEM (SKYLIGHT 2)
- → Gabapentin: off-label status, FDA-approved uses, the 2019 breathing-risk warning, dosing range, side-effect rates, and state controlled-substance scheduling
- → Guideline standing: both drugs rated “Recommended, Level I” by The Menopause Society’s 2023 Nonhormone Therapy Position Statement — a rating issued before Veozah’s boxed warning
- → Prices: Veozah and gabapentin cash prices, coupon prices, and the VEOZAH Savings Card terms — from GoodRx, SingleCare, and Astellas
- → Provider details: Midi Health and Sesame availability, insurance, prescribing, and controlled-substance policies — from each provider’s own site
Prices, savings-card terms, provider availability, and FDA labeling change. We re-check top drug and provider claims monthly and the full comparison quarterly. Last verified: July 2026.
Frequently asked questions
- Is Veozah better than gabapentin for hot flashes?
- Veozah is the only one of the two that’s FDA-approved specifically for hot flashes, and it worked well in large trials. Gabapentin also reduces hot flashes, especially night sweats and related sleep loss, but it’s off-label for menopause. No study has compared the two head-to-head, so no one can honestly say one beats the other; the better pick depends on your cost, sleep, safety, and situation.
- Is gabapentin FDA-approved for menopause hot flashes?
- No. Gabapentin is FDA-approved for shingles nerve pain and certain seizures. For hot flashes it’s used off-label, which is legal, common, and evidence-backed, but it was never formally approved for menopause. Off-label is not the same as unproven or compounded.
- Is Veozah a hormone?
- No. Veozah (fezolinetant) is a non-hormonal prescription pill. It works by blocking a brain signal (the NK3 receptor) that drives hot flashes when estrogen drops, rather than by replacing estrogen.
- Which is cheaper, Veozah or gabapentin?
- Gabapentin, by a wide margin. It’s a generic that usually costs about $9–$11 a month with a free coupon. Veozah runs about $690–$772 a month at full retail, roughly $474–$485 with a discount card, and has no generic. With commercial insurance, Veozah’s savings card can lower it to $0 the first month and about $30 per refill.
- Do you need liver tests with Veozah?
- Yes. You get a liver blood test before starting, then monthly for the first 3 months, and again at 6 and 9 months. You shouldn’t start Veozah if your liver enzymes (ALT or AST) or bilirubin are at least twice the top of the normal range, and you should stop and call your doctor if you notice signs of a liver problem like yellow skin, dark urine, or belly pain.
- Does gabapentin help with sleep?
- It can, when night sweats and poor sleep go together. A bedtime dose may calm the sweats and its drowsiness doubles as a sleep aid. The trade-off is possible next-day grogginess or dizziness, so discuss both the benefit and the side effects with your clinician.
- Can gabapentin cause swelling or weight gain?
- It can in a minority of people. Gabapentin’s labeling lists swelling in the limbs (about 8% of people, versus 2% on placebo) and some weight gain. It’s usually mild, but worth mentioning to your clinician if it appears.
- Who should not take Veozah?
- Women with known cirrhosis, severe kidney disease or end-stage renal disease, or who take a CYP1A2 inhibitor (a drug that blocks how the body clears Veozah). Anyone whose liver enzymes are already high shouldn’t start it. A clinician reviews your liver, kidneys, and full medication list first.
- Who should be careful with gabapentin?
- People who take opioids or other sedatives, drink alcohol regularly, have COPD or another lung condition, have kidney problems, are older, or need to drive and stay alert. The FDA warns of serious breathing problems with gabapentin in those higher-risk situations.
- Is gabapentin a controlled substance?
- Not federally. But a handful of states — including Alabama, Kentucky, North Dakota, Tennessee, Utah, Virginia, and West Virginia — classify it as a Schedule V controlled substance (Michigan did, then reversed in 2024). In those states, prescribing and refills are tighter, and getting it through telehealth can be harder. Check your state.
- Can either medication treat vaginal dryness or painful sex?
- No. Veozah and gabapentin treat hot flashes and night sweats only. Vaginal dryness, painful sex, and urinary symptoms need different treatment, often local vaginal estrogen or other options. If those are part of your picture, you need a broader plan.
- What if I have a history of breast cancer?
- Don’t choose based on a general article. Talk to your oncologist or a menopause clinician experienced with cancer survivors, especially if you take tamoxifen, an aromatase inhibitor, or ovarian suppression, since those affect which options are safe.
- Is Lynkuet an alternative to Veozah?
- Yes. Lynkuet (elinzanetant) is a newer FDA-approved non-hormonal option for moderate-to-severe hot flashes, approved in 2025, taken as 120 mg once daily at bedtime. It’s not the same drug as Veozah — it blocks two brain signals (NK1 and NK3) instead of one and may help sleep. It has its own safety profile, including liver-lab monitoring, a pregnancy contraindication, a daytime-drowsiness warning, and a grapefruit/interaction caution.
- Can online providers prescribe Veozah or gabapentin?
- Some online menopause providers can evaluate non-hormonal options and prescribe. Whether they can prescribe Veozah or gabapentin depends on the provider, the clinician, your state, controlled-substance rules for gabapentin, your labs, your medication list, and whether online care is appropriate for you. Don’t pick a provider just because you want one specific drug.
Still not sure which HRT program is right for you? Take our free 60-second matching quiz.
Take Find My HRT Path →Sources
Medical, regulatory, and pricing sources (19)
- U.S. FDA — FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause (Veozah approval, May 2023).
- DailyMed / Astellas — VEOZAH (fezolinetant) Prescribing Information (indication, 45 mg dosing, contraindications, liver monitoring; label revised February 2026).
- U.S. FDA — Drug Safety Communication: Boxed Warning added to Veozah for serious liver injury (Sept 2024; updated Dec 16, 2024).
- Lederman S, et al. Fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1). The Lancet, 2023.
- Johnson KA, et al. Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms (SKYLIGHT 2). J Clin Endocrinol Metab, 2023.
- The North American Menopause Society — 2023 Nonhormone Therapy Position Statement. Menopause, 2023.
- DailyMed — GABAPENTIN Prescribing Information (approved indications, warnings, adverse-reaction rates).
- U.S. FDA — Drug Safety Communication: Serious breathing problems with gabapentin and pregabalin (Dec 19, 2019).
- Guttuso T, et al. Randomized controlled trial of gabapentin 900 mg/day for hot flashes. Obstetrics & Gynecology, 2003.
- MGH Center for Women’s Mental Health — Gabapentin for Menopausal Vasomotor Symptoms.
- Drugs.com — Is gabapentin a controlled substance? (state Schedule V list; verified 2026) and gabapentin price guide.
- GoodRx — Veozah and gabapentin pricing (verified July 2026).
- SingleCare — Veozah and gabapentin pricing (verified July 2026).
- Astellas — VEOZAH Savings Program terms.
- DailyMed — LYNKUET (elinzanetant) Prescribing Information (dosing, warnings, contraindications; initial U.S. approval 2025).
- Drugs.com — patient reviews, gabapentin for hot flashes (individual experience only).
- Breastcancer.org — Veozah reviews (individual experience only).
- Midi Health — Menopause and Pricing & Insurance pages (availability, insurance, prescribing).
- Sesame — Menopause treatment and medication pages (cash-pay model, controlled-substance policy).
This page is independent editorial research from The HRT Index. It is not medical advice and not a substitute for care from a licensed clinician. It has not been medically reviewed by a clinician. We may earn a commission if you start care through some links on this page, at no extra cost to you; it never changes what we verify or recommend. Last verified: July 2026.
